7PP-25907-05596
3 vaccinations
3 coded responses
27 check-ins
3 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 913 / CA
- Registered
- 2021-07-13
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-07-12
Dose 1 — Pfizer-BioNTech
-
2021-07-13
Registered in v-safe
-
2021-07-13
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-07-14
-
2021-07-15
Survey response — days 1–6 daily, dose 1MedDRA: Dizziness — Feeling: FairFree text: LightheadedMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-07-16
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Fatigue or tiredness, NauseaAdult check-in
- 2021-07-17
- 2021-07-19
- 2021-07-26
-
2021-08-02
Dose 2 — Pfizer-BioNTech
- 2021-08-02
- 2021-08-03
- 2021-08-05
- 2021-08-06
- 2021-08-08
- 2021-08-09
- 2021-08-23
- 2021-08-30
- 2021-09-06
- 2021-09-13
- 2021-11-01
- 2022-01-31
-
2022-05-23
Dose 3 — Moderna
- 2022-05-23
-
2022-05-24
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain, Swelling · Headache, Fatigue or tirednessAdult check-in
-
2022-05-25
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Fatigue or tiredness · Be unable to work or attend schoolAdult check-in
-
2022-05-26
Health check-in — days 1–6 daily, dose 3Feeling: Good · Fatigue or tiredness · Be unable to work or attend schoolAdult check-in
- 2022-05-28
- 2022-06-06
-
2022-06-27
Survey response — day 35, dose 3MedDRA: Cough, Oropharyngeal pain, Respiratory tract congestion — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Cough, sore throat, and congestionMedDRA releases: 2024-11 · check-in free text available
-
2022-07-06
Survey response — day 42, dose 3MedDRA: Nasopharyngitis — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Cold symptomsMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-07-12 | Pfizer-BioNTech | No |
| 2 | 2021-08-02 | Pfizer-BioNTech | No |
| 3 | 2022-05-23 | Moderna | No |
Free text
Release 9 — days 1–6 daily, dose 1
Systemic reaction (other): Lightheaded
Release 12 — day 35, dose 3
Symptoms: Cough, sore throat, and congestion
Release 12 — day 42, dose 3
Symptoms: Cold symptoms
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SRO | Dizziness | ✓ | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release